LEO Pharma Gets EU Go-Ahead For Psoriasis Latecomer Brodalumab

psoriasis
LEO's Kyntheum recommended for EU approval in psoriasis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip